麻豆传媒

Publications

• Total number of publications: 86
• Total number of publications (excluding conference papers): 63
• Number of papers as corresponding author: 18
• Number of publications as 1st author: 39
• Total number of citations: 1,658 (on 06/01/26)
• H-index: 21
• Number of publications since 2018 (joined 麻豆传媒): 34

After starting at 麻豆传媒 (2018 to present)

86: Gristwood, K, Luli, S, Blair HJ, Rankin KS, Knight, JC. In Vivo Evaluation of a Self-Excitatory Near-Infrared ImmunoSCIFI Probe. Bioconjugate Chemistry. 2026, DOI: 10.1021/acs.bioconjchem.5c00506, in press

85: Chan CD, Brookes MJ, Pringle TA, Pal R, Tanwani R., Burt AD, Knight JC, Kumar ATN, Rankin KS. Investigating the mechanisms of preferential tumour uptake of indocyanine green in sarcoma. Journal of Pathology. 2025, 267(3), 315-328.

84: Sathiyajith, CW, Knight, JC, Kariuki, B, Edwards. PG. Chemistry and Biochemistry: Research Progress 2025, 3, 158-176.

83: Pringle T, Knight JC. . Organic & Biomolecular Chemistry 2025, 23(10), 2432-2438.

82: Pringle TA, Ramon-Gil E, Leslie J, Oakley F, Wright MC, Knight JC, Luli S. . Scientific Reports 2024, 14, 633.

81: Melemenidis S, Knight JC, Kersemans V, Perez-Balderas F, Zarghami N, Soto MS, Cornelissen B, Muschel RJ, Sibson NR. . International Journal of Molecular Sciences 2024, 25(13), 7160.

80: Cooke L, Gristwood K, Adamson K, Sims MT, Deary ME, Bruce D, Antoniou AN, Walden HR, Knight JC, Antoine-Brunet T, Joly M, Goyard D, Lanoë P-H, Berthet N, Kozhevnikov VN. . Dalton Transactions 2024, 53(37), 15501.

79: Luu T, Gristwood K, Knight JC, Jörg M. . Bioconjugate Chemistry 2024, 35(6), 715–731.

78: Gristwood K, Luli S, Rankin KS, Knight JC. . ACS Omega 2023, 8(50), 47905-47912.

77: Pringle TA, Coleman O, Kawamura A, Knight JC. . RSC Advances 2022, 12(43), 27716-27722.

76: Pringle TA, Chan CD, Luli S, Blair HJ, Rankin KS, Knight JC. . Bioconjugate Chemistry 2022, 33(8), 1564-1573.

75: Gristwood K, Luli S, Rankin KS, Knight JC. . Chemical Communications 2022, 83(58), 11689-11692.

74: Pringle T, Knight J, Chan C, Blair H, Luli S, Rankin K. . In: International Symposium on Radiopharmaceutical Sciences iSRS 2022. 2022, Nantes: Elsevier.

73: Gristwood K, Knight J. . In: International Symposium on Radiopharmaceutical Sciences iSRS 2022. 2022, Nantes: Elsevier.

72: Sirbu I, Stirling R, Knight JC, Milledge D, Davie C. . 16th BGA Young Geotechnical Engineers Symposium (YGES 2022), 麻豆传媒 upon Tyne, UK, 4-5 July 2022. DOI: https://doi.org/10.57711/kz8q-q554

71: Chan CD, Brookes MJ, Tanwani R, Hope C, Pringle TA, Knight JC, Rankin KS. . BioRxiv 2021. Submitted.

70: Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart S, Cornelissen B. . Journal of Nuclear Medicine 2020, 61(7), 1006-1013.

69: Baljer BC, Kolhe S, Chan CD, Nicoli F, Ghanbasha A, Brookes MJ, Gamie Z, Ghosh KM, Beckinsale TB, Saleh DB, Ragbir M, Gerrand CH, Jeys L, Knight JC, Petrides G, Rankin KS. . Cancer Letters 2020, 483, 1-11.

68: Poty S, Mandeylwala K, O'Neill E, Knight JC, Cornelissen B, Lewis JS. . Theranostics 2020, 10(13), 5802-5814.

67: Baljer BC, Kolhe S, Chan CD, Nicoli F, Ghanbasha A, Brookes MJ, Gamie Z, Ghosh KM, Beckinsale TB, Saleh DB, Ragbir M, Gerrand CH, Jeys L, Knight JC, Petrides G, Rankin KS. . Cancer Letters 2020, 483, 1-11.

66: Marculescu C, Lakshminarayanan A, Gault J, Knight JC, Folkes LK, Spink T, Robinson CV, Valis K, Davis BG, Cornelissen B. . Chemical Communications 2019, 55(76), 11342-11345.

65: Wilson T, Xavier MA, Knight JC, Verhoog S, Baguna Torres J, Mosley M, Hopkins SL, Wallington S, Allen D, Kersemans V, Hueting R, Smart S, Gouverneur V, Cornelissen B. . Journal of Nuclear Medicine 2019, 60(4), 504-510.

64: Knight JC, Mosley MJ, Kersemans V, Dias GM, Allen PD, Smart S, Cornelissen B. . Nuclear Medicine and Biology 2019, 70, 14-22.

63: Wuest M, Perreault A, Richter S, Knight JC, Wuest F. . Apoptosis 2019, 24, 221–244.

62: Knight JC, Cornelissen B. . In: Lewis JS; Windhorst AD; Zeglis BM, ed. Radiopharmaceutical Chemistry. Cham: Springer, 2019, pp.467-479.

61: Poty S, Knight J, Mandleywala K, Membreno R, Abdel-Atti D, Scholz W, Zeglis B, Cornelissen B, Lewis J. Pretargeted 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma: evaluating DNA-damage with 89Zr-PET. In: Nuclear Medicine and Biology. 2019, Elsevier.

60: Poty S, Knight JC, Donabedian P, Mandleywala K, Cornelissen B, Reiner T, Lewis JL. PET Imaging of DNA Damage Response following ²²⁵Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model. In: Journal of Medical Imaging and Radiation Sciences. 2019, Ottawa, Canada: Elsevier.

59: Knight JC, Cornelissen B. . In: Dong Soo Lee, ed. Radionanomedicine. Cham: Springer, 2018, pp.251-262.

58: Cornelissen B, Knight JC, Mukherjee S, Evangelista L, Xavier C, Caobelli F, Vecchio S, Rbah-Vidal L, Barbet J, de Jong M, van Leeuwen FWB. . European Journal of Nuclear Medicine and Molecular Imaging 2018, 45(13), 2442-2455.

57: Torres JB, Knight JC, Mosley MJ, Kersemans V, Koustoulidou S, Allen D, Kinchesh P, Smart S, Cornelissen B. . Molecular Imaging and Biology 2018, 20(2), 292-299.

56: Yaromina A, Knight J, Dubois L, Bauwens M, Biemans R, Lieuwes N, Cornelissen B, Lambin P. Non-invasive PET imaging of radiosensitive tumour regions using γH2AX-targeted immunoconjugate. In: Radiotherapy and Oncology. 2018, Barcelona, Spain: Elsevier.

55: Wilson TC, Xavier ME, Knight JC, Verhoog S, Baguna-Torres J, Mosley M, Hopkins SL, Wallington S, Allen D., Kersemans V, Hueting R, Smart S, Gouverneur V, Cornelissen B. PET imaging of Parp expression using [18F] olaparib. European Journal of Nuclear Medicine and Molecular Imaging. 2018, 45, S191-S191.

54: Knight JC, Mosley M, Kersemans V, Allen D, Smart S, Cornelissen B. Dual-isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours. European Journal of Nuclear Medicine and Molecular Imaging 2018, 45, S109-S110

53: Knight JC, Torres JB, Bravo LC, Kersemans V, Allen D, Kinchesh P, Smart S, Cornelissen B. . In: European Journal of Nuclear Medicine and Molecular Imaging. 2018, Düsseldorf, Germany: Springer Nature.

Before starting at 麻豆传媒 (2006-2017)

52: Knight JC, Mosley M, Uyeda HT, Cong M, Fan F, Faulkner S, Cornelissen B. . Molecular Pharmaceutics 2017, 14(7), 2307-2313.

51: Knight JC, Mosley MJ, Bravo LC, Kersemans V, Allen PD, Mukherjee S, O'Neill E, Cornelissen B. . Clinical Cancer Research 2017, 23(21), 6498-6504.

50: Knight JC, Koustoulidou S, Cornelissen B. . European Journal of Nuclear Medicine and Molecular Imaging 2017, 44(6), 1065-1078.

49: Mosley M, Knight JC, Koustoulidou S, Cornelissen B. . In: European Journal of Nuclear Medicine and Molecular Imaging. 2016, Barcelona, Spain: Springer Nature.

48: Koustoulidou S, Knight JC, Kersemans V, O'Neill E, Cornelissen B. . In: European Journal of Nuclear Medicine and Molecular Imaging. 2016, Barcelona, Spain: Springer Nature.

47: Knight JC, Amoroso AJ, Edwards PG, Singh N, Ward BD. . Dalton Transactions 2016, 45(26), 10630-10642.

46: Knight JC, Paisey SJ, Dabkowski AM, Marculescu C, Williams AS, Marshall C, Cornelissen B. . Dalton Transactions 2016, 45(15), 6343-6347.

45: Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala E, Zeglis BM, Lewis JS. . Journal of Nuclear Medicine 2016, 57(5), 771-776.

44: Saad FA, Knight JC, Kariuki BM, Amoroso AJ. . Dalton Transactions 2016, 45(25), 10280-10288.

43: Perreault A, Knight JC, Wang M, Way J, Wuest F. . Amino Acids 2016, 48(1), 65-74.

42: Xavier MA, Liu SH, Bugajski J, Knight JC, Marculescu C, Vallis K, Leppla S, Cornelissen B. . In: Journal of Nuclear Medicine. 2016, San Diego, USA: Society of Nuclear Medicine.

41: Knight JC, Mosley M, Bravo LC, Fokas E, Cornelissen B. . In: Journal of Nuclear Medicine. 2016, San Diego, USA: Society of Nuclear Medicine.

40: Knight JC, Mosley M, Stratford M, Uyeda HT, Cong M, Fan F, Faulkner S, Cornelissen B. . In: Journal of Nuclear Medicine. 2016, San Diego, USA: Society of Nuclear Medicine.

39: Konstantinou M, Knight JC, Hay T, Shaw P, Smalley M, Cornelissen B, Clarke A. . In: European Journal of Nuclear Medicine and Molecular Imaging. 2016, Barccelona, Spain: Springer Nature.

38: Knight JC, Topping C, Mosley M, Kersemans V, Falzone N, Fernandez-Varea JM, Cornelissen B. . European Journal of Nuclear Medicine and Molecular Imaging 2015, 42(11), 1707-1717.

37: Hillyar CRT, Knight JC, Vallis KA, Cornelissen B. . Current Drug Targets 2015, 16(6), 582-591.

36: Knight JC, Mosley M, Stratford MRL, Uyeda HT, Benink HA, Cong M, Fan F, Faulkner S, Cornelissen B. . Chemical Communications 2015, 51(19), 4055-4058.

35: Mosley M, Knight J, Neesse A, Michl P, Iezzi M, Kersemans V, Cornelissen B. . Journal of Nuclear Medicine 2015, 56(5), 745-751.

34: Knight JC, Topping C, Mosley M, Kersemans V, Fernandez-Varea J, Falzone N, Cornelissen B. . In: Journal of Nuclear Medicine. 2015, Baltimore, MD, USA: Society of Nuclear Medicine.

33: Knight JC, Mosley M, Stratford M, Uyeda HT, Cong M, Fan F, Faulkner S, Cornelissen B. . In: Journal of Nuclear Medicine. 2015, Baltimore, MD, USA: Society of Nuclear Medicine.

32: Knight JC, Paisey SJ, Marshall C, Cornelissen B. . In: European Journal of Nuclear Medicine and Molecular Imaging. 2015, Hamburg, Germany: Springer Nature.

31: Foerster C, Knight JC, Wuest M, Rowan B, Lapi SE, Amoroso AJ, Edwards PG, Wuest F. . MedChemComm 2014, 5(7), 958-962.

30: Cornelissen B, Able S, Kartsonaki C, Kersemans V, Allen PD, Cavallo F, Cazier J-B, Iezzi M, Knight J, Muschel R, Smart S, Vallis KA. . Journal of Nuclear Medicine 2014, 55(12), 2026-2031.

29: Sathiyajith CW, Knight JC, Kariuki BM, Edwards PG, Amoroso AJ. . Open Chemistry Journal 2014, 1, 15-20.

28: Knight JC, Cornelissen B. . American Journal of Nuclear Medicine and Molecular Imaging 2014, 4(2), 96-113.

27: Foerster C, Knight JC, Wuest M, Rowan B, Lapi SE, Amoroso AJ, Edwards PG, Wuest F. [⁶⁴Cu]Cu-CryptTM - A novel cryptate for copper-64?. Nuclear Medicine and Biology 2014, 41(7), 633.

26: Mosley M, Knight JC, Neesse A, Mihl P, Kersemans V, Cornelissen B. Radiolabelled cCPE for molecular imaging of tight junction changes during breast oncogenesis. In: Cancer Research. 2014, San Diego: American Association for Cancer Research.

25: Knight JC, Stratford M, Faulkner S, Uyeda HT, Cong M, Fan F, Cornelissen B. . In: Journal of Nuclear Medicine. 2014, St Louis, MO, USA: Society of Nuclear Medicine.

24: Knight JC, Wuest M, Saad FA, Wang M, Chapman DW, Jans H-S, Lapi SE, Kariuki BM, Amoroso AJ, Wuest F. Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditions. Dalton Transactions 2013, 42, 12005-12014.

23: Knight JC, Richter S, Wuest M, Way JD, Wuest F. . Organic and Biomolecular Chemistry 2013, 11(23), 3817-3825.

22: Saad FA, Knight JC, Kariuki BM, Amoroso AJ. Co-ordinative properties of a tripodal trisamide ligand with a capped octahedral preference. Dalton Transactions 2013, 42, 14826-14835.

21: Knight JC, Perreault A, Way JD, Wang M, Wuest FR. . In: Journal of Labelled Compounds and Radiopharmaceuticals. 2013, Jeju, Korea: Wiley.

20: Knight JC, Saad FA, Wuest M, Wang M, Lapi S, Kariuki BM, Amoroso AJ, Wuest FR. . In: Journal of Labelled Compounds and Radiopharmaceuticals. 2013, Jeju, Korea: Wiley.

19: Knight JC, Richter S, Way JD, Bouvet V, Wuest M, Wuest FR. . In: Journal of Labelled Compounds and Radiopharmaceuticals. 2013, Jeju, Korea: Wiley.

18: Knight JC, Prabaharan R, Amoroso AJ, Edwards PG, Ooi L-L. Synthesis and co-ordination chemistry of tris(picolyl-2-carboxyamido-6- pyridyl) methanol: A ligand with a strong preference for trigonal prismatic geometries. Polyhedron 2012, 31, 457-462.

17: Knight JC, Wuest FR. Nuclear (PET/SPECT) and optical imaging probes targeting the CXCR4 chemokine receptor. MedChemComm 2012, 3, 1039-1053.

16: Saad FA, Buurma NJ, Amoroso AJ, Knight JC, Kariuki BM. Co-ordination behaviour of a novel bisthiourea tripodal ligand: Structural, spectroscopic and electrochemical properties of a series of transition metal complexes. Dalton Transactions 2012, 41, 4608-4617.

15: Knight JC, Edwards PG, Paisey SJ. Fluorinated contrast agents for magnetic resonance imaging; A review of recent developments. RSC Advances 2011, 1, 1415-1425.

14: Knight JC, Hallett AJ, Brancale A, Paisey SJ, Clarkson RWE, Edwards PG. Evaluation of a fluorescent derivative of AMD3100 and its interaction with the CXCR4 chemokine receptor. ChemBioChem 2011, 12, 2692-2698.

13: Knight JC, Prabaharan R, Edwards PG, Amoroso AJ. Co-ordination of a new bis-terpyridine ligand with cupric perchlorate yielding a dinuclear M2L species. Journal of Molecular Structure 2011, 989, 86-90.

12: Carcedo C, Knight JC, Pope SJA, Fallis IA, Dervisi A. Chiral silver and gold rings: Synthesis and structural, spectroscopic, and photophysical properties of Ag and Au metallamacrocycles of bridging NHC ligands. Organometallics 2011, 30, 2553-2562.

11: Knight JC, Amoroso AJ, Edwards PG, Prabaharan R, Singh N. The co-ordination chemistry of bis(2,2′-bipyrid-6′-yl)ketone with first row transition metals: The reversible interconversion of a mononuclear complex and a dinuclear hemiketal containing species. Dalton Transactions 2010, 39, 8925-8936.

10: Edwards PG, Knight JC, Newman PD. Synthesis of (1R,4S,6R)-5,5,6-trimethyl-2-phosphabicyclo[2.2.2]octane and derivatives. Dalton Transactions 2010, 39, 3851-3860.

9: Knight JC, Alvarez S, Amoroso AJ, Edwards PG, Singh N. A novel bipyridine-based hexadentate tripodal framework with a strong preference for trigonal prismatic co-ordination geometries. Dalton Transactions 2010, 39, 3870-3883.

8: Knight JC, Prabaharan R, Ward BD, Amoroso AJ, Edwards PG, Kariuki BM. . Dalton Transactions 2010, 39(42), 10031-10033.

7: Knight JC, Fallis IA. 1,1′-(Ethane-1,2-diyl)bis(1,4,7-triazonane). Acta Crystallographica Section E 2010, 66.

6: Amoroso AJ, Edwards PG, Howard ST, Kariuki BM, Knight JC, Ooi L, Malik KMA, Stratford L, Al-Sudani A-RH. . Dalton Transactions 2009, (39), 8356-8362.

5: Knight JC, Saad FA, Amoroso AJ, Kariuki BM, Coles SJ. Rac-N-{6-[Bromo-(hydr-oxy)meth-yl]-2-pyrid-yl}pivalamide. Acta Crystallographica Section E 2009, 65.

4: Iglesias M, Beetstra DJ, Knight JC, Ooi L-L, Stasch A, Coles S, Male L, Hursthouse MB, Cavell KJ, Dervisi A, Fallis IA. Novel expanded ring N-heterocyclic carbenes: Free carbenes, silver complexes, and structures. Organometallics 2008, 27, 3279-3289.

3: Knight JC, Amoroso AJ, Prabaharan R, Edwards PG. Bis{N-[bis-(6-bromo-pyridin-2-yl)methyl-ene-N]ethane-1,2-diamine- 2 N,N′}nickel(II) bis-(perchlorate). Acta Crystallographica Section E 2007, 63, m1046-m1047.

2: Knight JC, Tatchell T, Fallis IA. 2-(Cyclo-hexyl-amino)-1,4-naphthoquinone. Acta Crystallographica Section E 2007, 63, o1226-o1227.

1: Knight JC, Amoroso AJ, Edwards PG, Ooi L-L. Catena-Poly[[[diaquacadmium(II)]-μ-2,2′- Bipyridine-6,6′- dicarboxylato] dihydrate]. Acta Crystallographica Section E 2006, 62, m3306-m3308.

Admissions - MSc Chemistry and MSc Drug Chemistry

• Articles

  • Gristwood K, Luli S, Blair HJ, Rankin KS, Knight JC. . Bioconjugate Chemistry 2026, 37(1), 93-99.
  • Pringle T, Knight JC. . Organic & Biomolecular Chemistry 2025, 23(10), 2432-2438.
  • Chan CD, Brookes MJ, Pringle TA, Pal R, Tanwani R, Burt AD, Knight JC, Kumar ATN, Rankin KS. . Journal of Pathology 2025, 267(3), 315-328.
  • Chan CD, Brookes MJ, Pringle TA, Pal R, Tanwani R, Burt AD, Knight JC, Kumar ATN, Rankin KS. . The Journal of Pathology 2025, 267(3), 315-328.
  • Pringle TA, Ramon-Gil E, Leslie J, Oakley F, Wright MC, Knight JC, Luli S. . Scientific Reports 2024, 14, 633.
  • Melemenidis S, Knight JC, Kersemans V, Perez-Balderas F, Zarghami N, Soto MS, Cornelissen B, Muschel RJ, Sibson NR. . International Journal of Molecular Sciences 2024, 25(13), 7160.
  • Cooke L, Gristwood K, Adamson K, Sims MT, Deary ME, Bruce D, Antoniou AN, Walden HR, Knight JC, Antoine-Brunet T, Joly M, Goyard D, Lanoë P-H, Berthet N, Kozhevnikov VN. . Dalton Transactions 2024, 53(37), 15501.
  • Gristwood K, Luli S, Rankin KS, Knight JC. . ACS Omega 2023, 8(50), 47905-47912.
  • Pringle TA, Coleman O, Kawamura A, Knight JC. . RSC Advances 2022, 12(43), 27716-27722.
  • Pringle TA, Chan CD, Luli S, Blair HJ, Rankin KS, Knight JC. . Bioconjugate Chemistry 2022, 33(8), 1564-1573.
  • Gristwood K, Luli S, Rankin KS, Knight JC. . Chemical Communications 2022, 83(58), 11689-11692.
  • Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart S, Cornelissen B. . Journal of Nuclear Medicine 2020, 61(7), 1006-1013.
  • Baljer BC, Kolhe S, Chan CD, Nicoli F, Ghanbasha A, Brookes MJ, Gamie Z, Ghosh KM, Beckinsale TB, Saleh DB, Ragbir M, Gerrand CH, Jeys L, Knight JC, Petrides G, Rankin KS. . Cancer Letters 2020, 483, 1-11.
  • Poty S, Mandeylwala K, O'Neill E, Knight JC, Cornelissen B, Lewis JS. . Theranostics 2020, 10(13), 5802-5814.
  • Marculescu C, Lakshminarayanan A, Gault J, Knight JC, Folkes LK, Spink T, Robinson CV, Valis K, Davis BG, Cornelissen B. . Chemical Communications 2019, 55(76), 11342-11345.
  • Wilson T, Xavier MA, Knight JC, Verhoog S, Baguna Torres J, Mosley M, Hopkins SL, Wallington S, Allen D, Kersemans V, Hueting R, Smart S, Gouverneur V, Cornelissen B. . Journal of Nuclear Medicine 2019, 60(4), 504-510.
  • Knight JC, Mosley MJ, Kersemans V, Dias GM, Allen PD, Smart S, Cornelissen B. . Nuclear Medicine and Biology 2019, 70, 14-22.
  • Torres JB, Knight JC, Mosley MJ, Kersemans V, Koustoulidou S, Allen D, Kinchesh P, Smart S, Cornelissen B. . Molecular Imaging and Biology 2018, 20(2), 292-299.
  • Knight JC, Mosley M, Uyeda HT, Cong M, Fan F, Faulkner S, Cornelissen B. . Molecular Pharmaceutics 2017, 14(7), 2307-2313.
  • Knight JC, Mosley MJ, Bravo LC, Kersemans V, Allen PD, Mukherjee S, O'Neill E, Cornelissen B. . Clinical Cancer Research 2017, 23(21), 6498-6504.
  • Knight JC, Amoroso AJ, Edwards PG, Singh N, Ward BD. . Dalton Transactions 2016, 45(26), 10630-10642.
  • Knight JC, Paisey SJ, Dabkowski AM, Marculescu C, Williams AS, Marshall C, Cornelissen B. . Dalton Transactions 2016, 45(15), 6343-6347.
  • Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala E, Zeglis BM, Lewis JS. . Journal of Nuclear Medicine 2016, 57(5), 771-776.
  • Saad FA, Knight JC, Kariuki BM, Amoroso AJ. . Dalton Transactions 2016, 45(25), 10280-10288.
  • Perreault A, Knight JC, Wang M, Way J, Wuest F. . Amino Acids 2016, 48(1), 65-74.
  • Knight JC, Topping C, Mosley M, Kersemans V, Falzone N, Fernandez-Varea JM, Cornelissen B. . European Journal of Nuclear Medicine and Molecular Imaging 2015, 42(11), 1707-1717.
  • Hillyar CRT, Knight JC, Vallis KA, Cornelissen B. . Current Drug Targets 2015, 16(6), 582-591.
  • Knight JC, Mosley M, Stratford MRL, Uyeda HT, Benink HA, Cong M, Fan F, Faulkner S, Cornelissen B. . Chemical Communications 2015, 51(19), 4055-4058.
  • Mosley M, Knight J, Neesse A, Michl P, Iezzi M, Kersemans V, Cornelissen B. . Journal of Nuclear Medicine 2015, 56(5), 745-751.
  • Foerster C, Knight JC, Wuest M, Rowan B, Lapi SE, Amoroso AJ, Edwards PG, Wuest F. . MedChemComm 2014, 5(7), 958-962.
  • Cornelissen B, Able S, Kartsonaki C, Kersemans V, Allen PD, Cavallo F, Cazier J-B, Iezzi M, Knight J, Muschel R, Smart S, Vallis KA. . Journal of Nuclear Medicine 2014, 55(12), 2026-2031.
  • Sathiyajith CW, Knight JC, Kariuki BM, Edwards PG, Amoroso AJ. . Open Chemistry Journal 2014, 1, 15-20.
  • Knight JC, Cornelissen B. . American Journal of Nuclear Medicine and Molecular Imaging 2014, 4(2), 96-113.
  • Foerster C, Knight JC, Wuest M, Rowan B, Lapi SE, Amoroso AJ, Edwards PG, Wuest F. [⁶⁴Cu]Cu-CryptTM - A novel cryptate for copper-64?. Nuclear Medicine and Biology 2014, 41(7), 633.
  • Knight JC, Wuest M, Saad FA, Wang M, Chapman DW, Jans H-S, Lapi SE, Kariuki BM, Amoroso AJ, Wuest F. Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditions. Dalton Transactions 2013, 42, 12005-12014.
  • Knight JC, Richter S, Wuest M, Way JD, Wuest F. . Organic and Biomolecular Chemistry 2013, 11(23), 3817-3825.
  • Saad FA, Knight JC, Kariuki BM, Amoroso AJ. Co-ordinative properties of a tripodal trisamide ligand with a capped octahedral preference. Dalton Transactions 2013, 42, 14826-14835.
  • Knight JC, Prabaharan R, Amoroso AJ, Edwards PG, Ooi L-L. Synthesis and co-ordination chemistry of tris(picolyl-2-carboxyamido-6- pyridyl) methanol: A ligand with a strong preference for trigonal prismatic geometries. Polyhedron 2012, 31, 457-462.
  • Knight JC, Wuest FR. Nuclear (PET/SPECT) and optical imaging probes targeting the CXCR4 chemokine receptor. MedChemComm 2012, 3, 1039-1053.
  • Saad FA, Buurma NJ, Amoroso AJ, Knight JC, Kariuki BM. Co-ordination behaviour of a novel bisthiourea tripodal ligand: Structural, spectroscopic and electrochemical properties of a series of transition metal complexes. Dalton Transactions 2012, 41, 4608-4617.
  • Knight JC, Edwards PG, Paisey SJ. Fluorinated contrast agents for magnetic resonance imaging; A review of recent developments. RSC Advances 2011, 1, 1415-1425.
  • Knight JC, Hallett AJ, Brancale A, Paisey SJ, Clarkson RWE, Edwards PG. Evaluation of a fluorescent derivative of AMD3100 and its interaction with the CXCR4 chemokine receptor. ChemBioChem 2011, 12, 2692-2698.
  • Knight JC, Prabaharan R, Edwards PG, Amoroso AJ. Co-ordination of a new bis-terpyridine ligand with cupric perchlorate yielding a dinuclear M2L species. Journal of Molecular Structure 2011, 989, 86-90.
  • Carcedo C, Knight JC, Pope SJA, Fallis IA, Dervisi A. Chiral silver and gold rings: Synthesis and structural, spectroscopic, and photophysical properties of Ag and Au metallamacrocycles of bridging NHC ligands. Organometallics 2011, 30, 2553-2562.
  • Knight JC, Amoroso AJ, Edwards PG, Prabaharan R, Singh N. The co-ordination chemistry of bis(2,2′-bipyrid-6′-yl)ketone with first row transition metals: The reversible interconversion of a mononuclear complex and a dinuclear hemiketal containing species. Dalton Transactions 2010, 39, 8925-8936.
  • Edwards PG, Knight JC, Newman PD. Synthesis of (1R,4S,6R)-5,5,6-trimethyl-2-phosphabicyclo[2.2.2]octane and derivatives. Dalton Transactions 2010, 39, 3851-3860.
  • Knight JC, Alvarez S, Amoroso AJ, Edwards PG, Singh N. A novel bipyridine-based hexadentate tripodal framework with a strong preference for trigonal prismatic co-ordination geometries. Dalton Transactions 2010, 39, 3870-3883.
  • Knight JC, Prabaharan R, Ward BD, Amoroso AJ, Edwards PG, Kariuki BM. . Dalton Transactions 2010, 39(42), 10031-10033.
  • Knight JC, Fallis IA. 1,1′-(Ethane-1,2-diyl)bis(1,4,7-triazonane). Acta Crystallographica Section E 2010, 66.
  • Amoroso AJ, Edwards PG, Howard ST, Kariuki BM, Knight JC, Ooi L, Malik KMA, Stratford L, Al-Sudani A-RH. . Dalton Transactions 2009, (39), 8356-8362.
  • Knight JC, Saad FA, Amoroso AJ, Kariuki BM, Coles SJ. Rac-N-{6-[Bromo-(hydr-oxy)meth-yl]-2-pyrid-yl}pivalamide. Acta Crystallographica Section E 2009, 65.
  • Iglesias M, Beetstra DJ, Knight JC, Ooi L-L, Stasch A, Coles S, Male L, Hursthouse MB, Cavell KJ, Dervisi A, Fallis IA. Novel expanded ring N-heterocyclic carbenes: Free carbenes, silver complexes, and structures. Organometallics 2008, 27, 3279-3289.
  • Knight JC, Amoroso AJ, Prabaharan R, Edwards PG. Bis{N-[bis-(6-bromo-pyridin-2-yl)methyl-ene-N]ethane-1,2-diamine- 2 N,N′}nickel(II) bis-(perchlorate). Acta Crystallographica Section E 2007, 63, m1046-m1047.
  • Knight JC, Tatchell T, Fallis IA. 2-(Cyclo-hexyl-amino)-1,4-naphthoquinone. Acta Crystallographica Section E 2007, 63, o1226-o1227.
  • Knight JC, Amoroso AJ, Edwards PG, Ooi L-L. Catena-Poly[[[diaquacadmium(II)]-μ-2,2′- Bipyridine-6,6′- dicarboxylato] dihydrate]. Acta Crystallographica Section E 2006, 62, m3306-m3308.

• Book Chapters

  • Sathiyajith C, Knight JC, Kariuki B, Edwards PG. . In: Kury, CMH, ed. Chemistry and Biochemistry: Research Progress Vol.3. BP International, 2025, pp.158-176.
  • Knight JC, Cornelissen B. . In: Lewis JS; Windhorst AD; Zeglis BM, ed. Radiopharmaceutical Chemistry. Cham: Springer, 2019, pp.467-479.
  • Knight JC, Cornelissen B. . In: Dong Soo Lee, ed. Radionanomedicine. Cham: Springer, 2018, pp.251-262.

• Conference Proceedings (inc. Abstracts)

  • Pringle T, Knight J, Chan C, Blair H, Luli S, Rankin K. . In: International Symposium on Radiopharmaceutical Sciences iSRS 2022. 2022, Nantes: Elsevier.
  • Gristwood K, Knight J. . In: International Symposium on Radiopharmaceutical Sciences iSRS 2022. 2022, Nantes: Elsevier.
  • Poty S, Knight J, Mandleywala K, Membreno R, Abdel-Atti D, Scholz W, Zeglis B, Cornelissen B, Lewis J. Pretargeted 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma: evaluating DNA-damage with 89Zr-PET. In: Nuclear Medicine and Biology. 2019, Elsevier.
  • Poty S, Knight JC, Donabedian P, Mandleywala K, Cornelissen B, Reiner T, Lewis JL. PET Imaging of DNA Damage Response following ²²⁵Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model. In: Journal of Medical Imaging and Radiation Sciences. 2019, Ottawa, Canada: Elsevier.
  • Wilson TC, Xavier ME, Knight JC, Verhoog S, Baguna-Torres J, Mosley M, Hopkins SL, Wallington S, Allen D, Kersemans V, Hueting R, Smart S, Gouverneur V, Cornelissen B. PET imaging of Parp expression using [18F] olaparib. In: European Journal of Nuclear Medicine and Molecular Imaging. 2018, Dusseldorf, Germany: Springer Nature.
  • Yaromina A, Knight J, Dubois L, Bauwens M, Biemans R, Lieuwes N, Cornelissen B, Lambin P. Non-invasive PET imaging of radiosensitive tumour regions using γH2AX-targeted immunoconjugate. In: Radiotherapy and Oncology. 2018, Barcelona, Spain: Elsevier.
  • Knight JC, Torres JB, Bravo LC, Kersemans V, Allen D, Kinchesh P, Smart S, Cornelissen B. Early detection of pancreaticc cancer in KPC mice by imaging DNA damage signalling. In: European Journal of Nuclear Medicine and Molecular Imaging. 2018, Düsseldorf, Germany: Springer Nature.
  • Knight JC, Mosley M, Kersemans V, Allen D, Smart S, Cornelissen B. Dual-Isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours. In: European Journal of Nuclear Medicine and Molecular Imaging. 2018, Dusseldorf, Germany: Springer Nature.
  • Knight JC, Mosley M, Stratford M, Uyeda HT, Cong M, Fan F, Faulkner S, Cornelissen B. In vivo pretargeted dual-modality imaging of HER2 and TAG-72 expression using the HaloTag enzyme. In: Journal of Nuclear Medicine. 2016, San Diego, USA: Society of Nuclear Medicine.
  • Koustoulidou S, Knight JC, Kersemans V, O'Neill E, Cornelissen B. Imaging p53 in pancreatic ductal adenocarcinoma (PDAC). In: European Journal of Nuclear Medicine and Molecular Imaging. 2016, Barcelona, Spain: Springer Nature.
  • Mosley M, Knight JC, Koustoulidou S, Cornelissen B. Imaging of pancreatic tumours in mice using radiolabelled anti-Claudin4 antibodies. In: European Journal of Nuclear Medicine and Molecular Imaging. 2016, Barcelona, Spain: Springer Nature.
  • Xavier MA, Liu SH, Bugajski J, Knight JC, Marculescu C, Vallis K, Leppla S, Cornelissen B. Development of radiolabelled engineered Bacillus anthracis toxic for MMP imaging. In: Journal of Nuclear Medicine. 2016, San Diego, USA: Society of Nuclear Medicine.
  • Konstantinou M, Knight JC, Hay T, Shaw P, Smalley M, Cornelissen B, Clarke A. Characterising In-111-anti-gamma H2AX-TAT in targeting the DNA damage signal associated with Wnt activated colorectal cancer. In: European Journal of Nuclear Medicine and Molecular Imaging. 2016, Barccelona, Spain: Springer Nature.
  • Knight JC, Mosley M, Bravo LC, Fokas E, Cornelissen B. 89Zr-anti-yH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma. In: Journal of Nuclear Medicine. 2016, San Diego, USA: Society of Nuclear Medicine.
  • Knight JC, Topping C, Mosley M, Kersemans V, Fernandez-Varea J, Falzone N, Cornelissen B. PET imaging of DNA damage. In: Journal of Nuclear Medicine. 2015, Baltimore, MD, USA: Society of Nuclear Medicine.
  • Knight JC, Paisey SJ, Marshall C, Cornelissen B. Microscale radiolabelling of antibodies with zirconium-89 for positron emission tomography. In: European Journal of Nuclear Medicine and Molecular Imaging. 2015, Hamburg, Germany: Springer Nature.
  • Knight JC, Mosley M, Stratford M, Uyeda HT, Cong M, Fan F, Faulkner S, Cornelissen B. Development of an enzymatic pretargeting strategy for dual-modality imaging. In: Journal of Nuclear Medicine. 2015, Baltimore, MD, USA: Society of Nuclear Medicine.
  • Mosley M, Knight JC, Neesse A, Mihl P, Kersemans V, Cornelissen B. Radiolabelled cCPE for molecular imaging of tight junction changes during breast oncogenesis. In: Cancer Research. 2014, San Diego: American Association for Cancer Research.
  • Knight JC, Stratford M, Faulkner S, Uyeda HT, Cong M, Fan F, Cornelissen B. Dual-modality HaloTag ligands for SPECT/CT and optical imaging. In: Journal of Nuclear Medicine. 2014, St Louis, MO, USA: Society of Nuclear Medicine.
  • Knight JC, Saad FA, Wuest M, Wang M, Lapi S, Kariuki BM, Amoroso AJ, Wuest FR. Synthesis, characterisation and radiopharmalogical evaluation of a novel copper-64 complex derived from a tripodal N₄S ligand. In: Journal of Labelled Compounds and Radiopharmaceuticals. 2013, Jeju, Korea: Wiley.
  • Knight JC, Richter S, Way JD, Bouvet V, Wuest M, Wuest FR. Synthesis and evaluation of an ¹⁸F-labeled norbornene derivative for rapid copper-free click chemistry reactions. In: Journal of Labelled Compounds and Radiopharmaceuticals. 2013, Jeju, Korea: Wiley.
  • Knight JC, Perreault A, Way JD, Wang M, Wuest FR. Radiolabelling annexin-V with fluorine-18: Random and site-seletive approaches. In: Journal of Labelled Compounds and Radiopharmaceuticals. 2013, Jeju, Korea: Wiley.

• Reviews

  • Luu T, Gristwood K, Knight JC, Jörg M. . Bioconjugate Chemistry 2024, 35(6), 715–731.
  • Baljer BC, Kolhe S, Chan CD, Nicoli F, Ghanbasha A, Brookes MJ, Gamie Z, Ghosh KM, Beckinsale TB, Saleh DB, Ragbir M, Gerrand CH, Jeys L, Knight JC, Petrides G, Rankin KS. . Cancer Letters 2020, 483, 1-11.
  • Wuest M, Perreault A, Richter S, Knight JC, Wuest F. . Apoptosis 2019, 24, 221–244.
  • Cornelissen B, Knight JC, Mukherjee S, Evangelista L, Xavier C, Caobelli F, Vecchio S, Rbah-Vidal L, Barbet J, de Jong M, van Leeuwen FWB. . European Journal of Nuclear Medicine and Molecular Imaging 2018, 45(13), 2442-2455.
  • Knight JC, Koustoulidou S, Cornelissen B. . European Journal of Nuclear Medicine and Molecular Imaging 2017, 44(6), 1065-1078.